Global Insulin Pens, Syringes, Pumps And Injectors Market Projected to Grow at 6.9% CAGR, Reaching $10832.91 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Insulin Pens, Syringes, Pumps And Injectors Industry Market Size Be by 2025?
Recent years have seen an exponential growth in the market size of insulin pens, syringes, pumps, and injectors. The market's worth is expected to surge from $21.6 billion in 2024 to $24.26 billion in 2025, projecting a compound annual growth rate (CAGR) of 12.3%. The significant growth during the historic period can be credited to urban development and infrastructural progress, rural area electrification, industrial development, and the incorporation of renewable energy.

What's the Long-Term Growth Forecast for the Insulin Pens, Syringes, Pumps And Injectors Market Size Through 2029?
Anticipated improvement in the market size of insulin pens, syringes, pumps, and injectors is set to be significant in the upcoming years, with predictions showing a potential rise to $37.86 billion by 2029. This implicates a compound annual growth rate (CAGR) of 11.8%. Several factors contribute to this surge in the market during the forecast period, including energy transition, transportation electrification, integration of smart grids and IoT, expansion of 5G, and renovation of ageing infrastructures. The period ahead is also expected to see trends like high-voltage direct current (HVDC) cables, fire-proof insulation, integration of fiber optics, utilisation of eco-friendly materials, along with customization and specialization.

View the full report here:
https://www.thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-global-market-report

What Are the Key Growth Drivers Fueling the Insulin Pens, Syringes, Pumps And Injectors Market Expansion?
The global surge in diabetes incidence is fueling the expansion of the insulin pens, syringes, pumps, and injectors market. Diabetes is a chronic disorder characterized by the body's struggle to control blood sugar due to inadequate insulin production or ineffective insulin usage, which results in increased blood sugar levels. The rise in obesity, unhealthy dietary habits, sedentary lifestyles, and the aging population are contributing to higher rates of diabetes globally. This increase in diabetes cases propels the growth of the insulin delivery devices market, as a greater number of people require insulin pens, syringes, pumps, and injectors for effective and convenient management of their condition. As per the report from the International Diabetes Federation, a Belgium-based organization comprising over 240 national diabetes groups, in 2021, about 537 million adults around the world were living with diabetes, and this number is projected to climb to 783 million by 2045. Thus, the rising prevalence of diabetes worldwide is sparking the expansion of the insulin pens, syringes, pumps, and injectors market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3806&type=smp

What Are the Key Trends Driving Insulin Pens, Syringes, Pumps And Injectors Market Growth?
Numerous businesses in the sector of insulin pens, syringes, pumps, and injectors are directing their focus onto the technological evolution of insulin delivery systems to ensure the efficient and safe delivery of insulin. These insulin delivery systems are specifically designed instruments to aid diabetic patients by way of devices like pens, syringes, pumps, and injectors, guaranteeing accurate and effective control of blood sugar levels. For instance, in June 2024, Insulet Corporation, a medical equipment manufacturer based in the USA, introduced Omnipod 5. This new introduction is an automated insulin delivery system, devoid of tubes, designed for patients aged two and older with type 1 diabetes. Further, it is the first system with integration capability with the Dexcom G6 and Abbott FreeStyle Libre 2 Plus continuous glucose monitors, providing it a unique compatibility with leading CGM brands, thereby enhancing diabetes management.

How Is the Insulin Pens, Syringes, Pumps And Injectors Market Segmented?
The insulin pens, syringes, pumps and injectors market covered in this report is segmented -

1) By Type: Pens, Injectors And Pumps, Syringes
2) By Pens: Reusable, Disposable
3) By Pumps: Tubed Pumps, Tubeless Pumps
4) By End Users: Hospitals, Homecare, Other End Users

Subsegments:
1) By Pens: Disposable Insulin Pens, Reusable Insulin Pens
2) By Injectors And Pumps: Insulin Injectors, Insulin Pumps, Traditional Insulin Pumps, Patch Insulin Pumps
3) By Syringes: Disposable Syringes, Reusable Syringes

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3806&type=smp

Which Companies Are Leading the Charge in Insulin Pens, Syringes, Pumps And Injectors Market Innovation?
Major companies operating in the insulin pens, syringes, pumps and injectors market include Novo Nordisk A/S, Eli Lilly and Company, Medtronic plc, Abbott Laboratories, Insulet Corporation, Sanofi Aventis, F. Hoffmann-La Roche Ltd, Becton Dickinson and Company, Animas Corporation, Ypsomed Holding AG, Dickinson and Company, Valeritas Inc., MannKind Corporation, Tandem Diabetes Care Inc., Biocon Ltd., B. Braun Melsungen AG, Terumo Corporation, Teleflex Incorporated, Nipro Corporation, Smiths Medical Inc., Owen Mumford, UltiMed Inc., Ypsomed Holding, Ascensia Diabetes Care, Trividia Health, ARKRAY Inc., AgaMatrix Inc., Medline Industries LP, Gerresheimer AG, West Pharmaceutical Services Inc., SHL Medical AG, Zhejiang POCTech Medical Co.Ltd., Jiangsu Wanhai Medical Instruments Co. Ltd.

Which Regions Are Leading the Global Insulin Pens, Syringes, Pumps And Injectors Market in Revenue?
North America was the largest region in the global insulin pens, syringes, pumps, and injectors devices and equipment market in 2023. Asia-Pacific was the second-largest region in insulin pens, syringes, pumps, and injectors devices and equipment market. The regions covered in the insulin pens, syringes, pumps and injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3806

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.